Display options
Share it on
Full text links
Springer

Clin Pharmacokinet. 1996 Dec;31(6):410-22. doi: 10.2165/00003088-199631060-00002.

Pharmacokinetics of opioids in renal dysfunction.

Clinical pharmacokinetics

G Davies, C Kingswood, M Street

Affiliations

  1. University of Brighton, England.

PMID: 8968655 DOI: 10.2165/00003088-199631060-00002

Abstract

Patients with renal insufficiency commonly require the administration of an opioid analgesic to provide adequate pain relief. The handling of morphine, pethidine (meperidine) and dextropropoxyphene in patients with renal insufficiency is complicated by the potential accumulation of metabolites. While morphine itself remains largely unaffected by renal failure, accumulation, as denoted by an increase in both mean peak concentrations and the area under the concentration-time curve, of both the active metabolite (morphine-6-glucuronide) and the principal metabolite (morphine-3-glucuronide, thought to possess opiate antagonist properties) have been reported. The increased elimination half-lives of the toxic metabolites norpethidine and norpropoxyphene in patients with poor renal function administered pethidine and dextropropoxyphene, respectively, makes their routine use ill advised. Case reports of prolonged narcosis associated with the use of both codeine and dihydrocodeine in patients with renal insufficiency call for care to be used when prescribing these agents under such conditions. Although the pharmacokinetics of buprenorphine, alfentanil, sufentanil and remifentanil change little in patients with renal failure, the continuous administration of fentanyl can lead to prolonged sedation.

Cited by

References

  1. Br J Anaesth. 1982 Aug;54(8):871-7 - PubMed
  2. Anesth Analg. 1988 Mar;67(3):268-71 - PubMed
  3. Clin Pharmacol Ther. 1984 May;35(5):641-5 - PubMed
  4. Clin Toxicol. 1979 Oct;15(3):267-71 - PubMed
  5. Anesthesiology. 1984 Nov;61(5):502-6 - PubMed
  6. J Pharm Pharmacol. 1989 Sep;41(9):654-7 - PubMed
  7. Am J Kidney Dis. 1983 Nov;3(3):155-93 - PubMed
  8. Clin Pharmacol Ther. 1976 Nov;20(5):535-40 - PubMed
  9. Anesth Analg. 1993 Nov;77(5):1031-40 - PubMed
  10. Ther Drug Monit. 1991 Jan;13(1):1-23 - PubMed
  11. J Clin Pharmacol. 1976 May-Jun;16(5-6):245-56 - PubMed
  12. Br J Clin Pharmacol. 1992 Jul;34(1):53-9 - PubMed
  13. Br J Pharmacol Chemother. 1963 Apr;20:285-98 - PubMed
  14. Br J Anaesth. 1989 Jul;63(1):60-7 - PubMed
  15. J Pharmacol Exp Ther. 1977 Jan;200(1):245-53 - PubMed
  16. Lancet. 1988 Apr 9;1(8589):828 - PubMed
  17. Br J Anaesth. 1989 Jan;62(1):28-32 - PubMed
  18. Anesthesiology. 1985 Dec;63(6):708-10 - PubMed
  19. Clin Pharmacol Ther. 1979 Oct;26(4):473-82 - PubMed
  20. Br J Anaesth. 1984 Aug;56(8):813-9 - PubMed
  21. Pharmacol Rev. 1960 Dec;12:383-446 - PubMed
  22. Clin Pharmacol Ther. 1993 Aug;54(2):158-67 - PubMed
  23. Eur J Clin Pharmacol. 1987;32(4):377-82 - PubMed
  24. Br Med J (Clin Res Ed). 1986 Jun 14;292(6535):1548-9 - PubMed
  25. Anesth Analg. 1982 Dec;61(12):968-71 - PubMed
  26. Acta Anaesthesiol Scand Suppl. 1982;74:66-9 - PubMed
  27. Life Sci. 1990;47(6):579-85 - PubMed
  28. Postgrad Med J. 1980 Oct;56(660):736-7 - PubMed
  29. Am J Forensic Med Pathol. 1992 Mar;13(1):42-3 - PubMed
  30. Clin Pharmacol Ther. 1972 Nov-Dec;13(6):923-30 - PubMed
  31. Clin Pharmacokinet. 1976;1(3):219-30 - PubMed
  32. Anesth Analg. 1989 May;68(5):579-83 - PubMed
  33. Clin Pharmacol Ther. 1990 Jan;47(1):12-9 - PubMed
  34. J Anal Toxicol. 1984 Mar-Apr;8(2):68-74 - PubMed
  35. Eur J Clin Pharmacol. 1983;25(3):419-24 - PubMed
  36. Anesthesiology. 1988 Oct;69(4):527-34 - PubMed
  37. Lancet. 1985 Apr 6;1(8432):784-6 - PubMed
  38. Br J Clin Pharmacol. 1989 Apr;27(4):499-505 - PubMed
  39. Intensive Care Med. 1986;12(5):359-65 - PubMed
  40. Ann Intern Med. 1977 Jun;86(6):738-41 - PubMed
  41. Acta Anaesthesiol Belg. 1979 Dec;30(4):247-54 - PubMed
  42. Br J Anaesth. 1993 May;70(5):511-4 - PubMed
  43. Anesthesiology. 1991 Jan;74(1):53-63 - PubMed
  44. Clin Pharmacol Ther. 1982 Feb;31(2):157-67 - PubMed
  45. Clin Pharmacol Ther. 1975 Jan;17(1):15-20 - PubMed
  46. Clin Pharmacokinet. 1995 Oct;29(4):231-42 - PubMed
  47. Anesthesiology. 1982 Dec;57(6):458-67 - PubMed
  48. Br J Anaesth. 1991 Jan;66(1):103-7 - PubMed
  49. Anaesthesia. 1992 Oct;47(10):852-4 - PubMed
  50. Anesthesiology. 1994 Jul;81(1):87-93 - PubMed
  51. Ann Neurol. 1983 Feb;13(2):180-5 - PubMed
  52. Br Med J (Clin Res Ed). 1985 Mar 9;290(6470):740-2 - PubMed
  53. Br Med J (Clin Res Ed). 1983 Feb 5;286(6363):438-9 - PubMed
  54. Anesthesiology. 1979 Apr;50(4):342-9 - PubMed
  55. Clin Pharmacol Ther. 1980 May;27(5):665-70 - PubMed
  56. Drug Intell Clin Pharm. 1982 Nov;16(11):849-54 - PubMed
  57. Br J Anaesth. 1986 Feb;58(2):234-45 - PubMed
  58. Anesth Analg. 1987 Jan;66(1):53-6 - PubMed
  59. Br J Clin Pharmacol. 1986 Jul;22(1):55-9 - PubMed
  60. Clin Pharmacol Ther. 1980 Jul;28(1):106-14 - PubMed
  61. Anesthesiology. 1993 Nov;79(5):881-92 - PubMed
  62. Clin Pharm. 1986 Jan;5(1):15-6 - PubMed
  63. Arch Int Pharmacodyn Ther. 1982 May;257(1):4-19 - PubMed
  64. Eur J Clin Pharmacol. 1985;28(2):171-5 - PubMed
  65. Br J Anaesth. 1990 Mar;64(3):276-82 - PubMed
  66. Br J Anaesth. 1990 May;64(5):547-50 - PubMed
  67. Br J Anaesth. 1979 Aug;51(8):741-5 - PubMed
  68. Drug Metab Rev. 1976;5(1):43-140 - PubMed
  69. Br Med J (Clin Res Ed). 1983 Sep 10;287(6394):751-2 - PubMed
  70. Clin Pharmacol Ther. 1980 Apr;27(4):508-14 - PubMed
  71. Lancet. 1985 May 11;1(8437):1100 - PubMed
  72. Drug Alcohol Depend. 1980 Mar;5(3):197-205 - PubMed
  73. Clin Pharmacokinet. 1982 Sep-Oct;7(5):421-33 - PubMed
  74. Anesthesiology. 1993 Nov;79(5):893-903 - PubMed
  75. Clin Pharmacokinet. 1978 Sep-Oct;3(5):352-68 - PubMed
  76. Acta Anaesthesiol Scand. 1993 Feb;37(2):176-80 - PubMed
  77. Anesthesiology. 1987 Mar;66(3):327-31 - PubMed
  78. Eur J Clin Pharmacol. 1990;38(2):121-4 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources